Trials / Recruiting
RecruitingNCT05661318
AHC Ballana Heart Study
Aswan Heart Centre - Ballana Heart Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,000 (estimated)
- Sponsor
- Magdi Yacoub Heart Foundation · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This Study is designed to assess CVD incidence, prevalence, progression and related risk factors, including genetic background. It will provide an important base for all cardiovascular research activities in our centre and help in designing future studies and guide policy.
Detailed description
Background Population-based longitudinal studies are a cornerstone in understanding current disease landscapes affecting communities and collecting reliable data to guide prevention and treatment strategies. In Egypt there is pressing need of collecting reliable data on cardiovascular disease (CVD) in defined populations. Objectives Defining the cardiovascular phenotype, genotype as well as OMICS and risk factors for CVD in a defined population in Egypt with follow up for up to 30 years Methods As a first step, a random representative sample of 1,200 households from the Ballana population will be created. Following inclusion, patients will be screened for their cardiovascular profile and followed up for changes in their profile and cardiovascular events continuously every year in high risk patients and every 3 years for the rest of the participants for a period of 30 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Risk assessment | Collect clinical, laboratoary and genetics data from the participants after informed consent |
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2050-12-31
- Completion
- 2055-01-31
- First posted
- 2022-12-22
- Last updated
- 2024-05-29
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05661318. Inclusion in this directory is not an endorsement.